Lv21
146 积分 2024-04-22 加入
Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6–48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine (P2-11.016)
27分钟前
待确认
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
4小时前
已完结
Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation
3个月前
已完结
Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder
9个月前
已关闭
Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis
10个月前
已完结
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders
10个月前
已完结
Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China
1年前
已完结
皖公网安备34019202002308
